| Frontiers in Neurology | |
| Case report: COVID-19-associated refractory thrombotic thrombocytopenic purpura complicated with Guillain-Barré syndrome | |
| Neurology | |
| Shenjian Chen1  Wei Huang1  Zhiyong Sheng1  Rui Zhou1  Xinyue Zhang2  Fang Li2  Qinghua Luo3  | |
| [1] Department of Neurological Intensive Care Unit, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;Department of Neurology, The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China;The Second Affiliated Hospital of Nanchang University, Nanchang, Jiangxi, China; | |
| 关键词: COVID-19; Guillain-Barré syndrome; thrombotic thrombocytopenic purpura; ADAMTS-13; rituximab; | |
| DOI : 10.3389/fneur.2023.1199889 | |
| received in 2023-04-05, accepted in 2023-05-02, 发布年份 2023 | |
| 来源: Frontiers | |
PDF
|
|
【 摘 要 】
Thrombotic thrombocytopenic purpura (TTP), a rare and lethal thrombotic microangiopathy, is an autoimmune disease that can be triggered by viral infections such as COVID-19. This condition is characterized by hemolytic microangiopathy, thrombocytopenia, and neurologic alterations, possibly accompanied by fever and renal damage. Moreover, more than 220 patients with Guillain-Barré syndrome (GBS) have been reported in association with the COVID-19 infection. In this report, we present a case of a patient who developed refractory TTP complicated by GBS following a SARS-CoV-2 infection. We aimed to highlight the importance of accurately diagnosing neurological complications associated with a COVID-19 infection and to demonstrate our strategies for treating a patient with COVID-19 infection-related refractory TTP complicated by GBS.
【 授权许可】
Unknown
Copyright © 2023 Zhou, Chen, Luo, Zhang, Li, Huang and Sheng.
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO202310101785303ZK.pdf | 1369KB |
PDF